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Abstract 
In some leeches like Hirudo medicinalis, any kind of stimulation (surgical wound or growth factor 
injection) provokes the botryoidal tissue response. This peculiar tissue, localized in the loose 
connective tissue between gut and body wall, is formed by granular botryoidal cells and flattened 
endothelial-like cells. Under stimulation, the botryoidal tissue changes its shape to form new capillaries. 
In mammals, the molecular regulation of the angiogenic phenotype requires coordinated input from a 
number of signalling molecules: among them the GTPase Ras is one of the major actor. In our current 
study, we determine whether Ras activation alone would be sufficient to drive vessels formation from 
leech botryoidal tissue. Our findings indicate that assembly and disassembly of actin filaments 
regulated by Ras protein is involved in morphological modification of botryoidal tissue cells during 
leech angiogenic process. 
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Introduction 
 
Hirudo medicinalis shows a simple anatomical 
organization: a muscular-cutaneous sac, practically 
avascular (de Eguileor et al., 2001a, 2004), 
containing several organs embedded in a loose 
connective tissue. In Hirudidae between the gut and 
the body wall, a peculiar tissue, the botryoidal tissue 
is localized. This multifunctional tissue, formed by 
clusters of roundish granular botryoidal cells, and 
small, flattened, endothelial-like cells, displaying 
myelo/erythroid and storage functions (Sawyer, 
1986), is involved in angiogenesis (de Eguileor et al., 
2001b). We have previously demonstrated that both 
surgical and biochemical stimuli (i.e. injection of 
cytokines such as vascular endothelial cell growth 
factor (VEGF), basic fibroblast growth factor (bFGF) 
or granulocyte Macrophage Colony-Stimulating 
(GM-CSF) evoke in botryoidal tissue cells, 
angiogenic signalling pathways analogous to those 
observed in vertebrates (Grimaldi et al. 2006; 
Tettamanti et al., 2003a; Tettamanti et al., 2003b, 
2006). Immediately after stimuli, botryoidal tissue 
changes its shape from a solid cord of cells to a 
tubular, pre-vascular structure through a dehiscence 
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process. In this contest, the remodelling is 
characterized by marked cellular changes: thinning, 
flattening and tapering of these cells allow the 
definition of lumen, and the increase in diameter 
and length of new capillary. The molecular control of 
the complex angiogenic phenotype requires 
coordinated input from a number of signalling 
molecules. In mammalian, one of basic regulators of 
the angiogenic response is Ras. This GTPase, due 
to its involvement in endothelial cell motility 
(Sosnowski et al., 1993; Fox et al., 1994), plays an 
important role in several systems including bFGF-
mediated wound closure and pro-angiogenic 
response to VEGF. Its activation is also required for 
the proliferation, migration, and branching 
morphogenesis of vascular endothelial cells 
(Meadows et al., 2001, 2004). Ras protein controls 
signal transduction pathways (Carpenter 2000; 
Kranenburg and Moolenaar, 2001) leading to 
gene expression changes and cell motility through 
the MAP/ERK kinase cascade. (Ehrhardt et al., 
2002). 
The focus of the present work is to demonstrate 
that as in vertebrates (Joneson et al., 1996; Leblanc 
et al., 1998; Meadows et al., 2001; Kranenburg, 
2004; Meadows et al., 2004; Serban et al., 2008) 
Ras plays a key role in the leech angiogenic 
process by remodelling actin cytoskeleton even in 
absence of VEGF, generally considered the 
principal regulator of angiogenesis. 
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Fig. 1 A-J Morphological and immunocytochemical analysis of control and VEGF stimulated botryoidal tissue 
cells. Semi-thin (A, C) and thin (B, D-F) sections of control and VEGF stimulated cultured botryoidal tissue. The 
control tissue is formed by clusters of botryoidal cells with a granule-filled cytoplasm (arrowheads in A and B) and 
endothelial cells (arrows in A and B). After 6 h from VEGF administration, large cavities (lv in C and D) lined by 
granulated botryoidal cells (arrowheads in B and C) and by flattened endothelial-like cells (arrows in C, D) are 
visible. Bundles of actin filaments are visible at TEM in the cytoplasm of VEGF stimulated endothelial cells 
(arrowheads in F), but not in the control untreated endothelial cells (E). In both VEGF stimulated (G, H) and 
VEGF+anti-RAS (I, J) treated botryoidal tissue, the diffuse distribution of actin, lacking a specific organization in 
bundles is detected by immunofluorescence using a specific monoclonal antibody anti-beta actin (G, I), while F-
actin (H, J) is stained using -conjugated phalloidin. The formation of actin filaments is highly reduced in 
VEGF+anti-RAS treated endothelial cells (J). Bars in A, C, G-J: 100 μm; bar in B: 4 μm; bar in D:10 μm; bars in E, 
F: 200 nm. 
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Material and Methods 
 
Animals and Treatments 
Leeches (Hirudo medicinalis, Annelida, 
Hirudinea, Hirudidae from Ricarimpex, Eysines, 
France) were kept in water at 19 - 20 °C in aerated 
tanks. Animals were fed weekly with calf blood. 
Before each experiment, leeches were 
anaesthetized with a 10 % ethanol solution. 
 
Cell culture 
Leeches were longitudinally dissected on the 
dorsal side using sterilized razor blades and 
botryoidal tissue cells, localized between the 
muscular body wall and the gut, were harvested 
from the animals using sterilized forceps. Cells were 
then transferred to a single well of 24 well plates in 
400 ml of tissue culture medium containing DMEM 
medium (Celbio, Milan, Italy) modified by dilution 
(1:4) to reach iso-osmolality and supplemented with 
1% glutamine,10 % fetal bovine serum and 1 % 
antibiotic antimycotic solution (Sigma, St. Louis, 
MO) as already described (Grimaldi et al., 2008, 
2009). Cells were maintained at 20 °C for 24 h 
before to be differently processed. 
 
Cell culture and VEGF administration 
To evaluate the effect of VEGF165 on 
botryoidal tissue cells shape modification cells were 
plated in 24-multiwell plates in medium alone or in 
medium supplemented with 100 ng/ml of VEGF165. 
All cultures were performed in quadruplicate and 
scored at 6 in vitro using an inverted Olympus 
microscope (Olympus, Tokyo, Japan). Data were 
recorded with a DS-5M-L1 digital camera system 
(Nikon, Tokyo, Japan). 
 
Cell culture and transformation assays 
Plasmids (kindly gifted by Renata Zippel, 
University of Milano, Italy) utilized for botryoidal cells 
transfection were: pc3mycRas61, coding for a 
constitutively activated form of Ras (Glu61 
substituted with Leu) and pEGFP-CI (coding for a 
green fluorescence protein). DNA transfection of 
botryoidal tissue cells were performed using calcium 
phosphate precipitation (calcium phosphate kit, 
Sigma). Cells were kept in a 1xHEPES-buffered 
saline solution pH 7.05 (Sigma) containing 8.4 μl 
CaCl2 (2,5M), 2,5 μg of pEGFP-CI and 4.5 μg of 
pc3mycRas61. Control experiments were performed 
using a 1xHEPES-buffered saline solution pH 7.05 
containing only 8.4 μl CaCl2 (2,5M) and 7 μg of 
pEGFP-CI. After 20 h the medium containing DNA 
were removed and cells were treated for 2 minutes 
with a 50 % glycerol in 1xHEPES-buffered saline 
solution pH 7.05 to increase efficiency of 
transfection. Cells were then plated in culture 
medium and analyzed after 3 days. Transfection 
efficiency was visualized by using a fluorescence 
microscope Olympus (excitation/emission filters 
490/525 nm for fluorescein isothiocyanate-FITC). 
 
Inhibition of Ras signalling in Ras transformed cells  
An antibody anti-Ras and the synthetic inhibitor 
of the MAP kinase pathway PD 098059, (2′-amino-
3′methoxyflavone, Alexis, Bingham, U.K.) were used 
to block Ras activity (Alessi et al., 1995). For 
antibody-mediated neutralization experiments, 1 μg 
of the polyclonal antibody anti-rabbit Ras 
(StressGen Biotechnologies Corporation, Victoria, 
BC, Canada), was added to the medium in which 
GFP/Ras61 co-transfected cells or VEGF stimulated 
cells were cultured. PD 098059 was dissolved in 
DMSO to give a final concentration of 37 μM and 
stored at -80 °C. GFP/Ras61 transformed cells were 
then cultured in a medium containing PD 098059 to 
a final concentration of 100 μM. Cells plated in both 
modified culture medium were analyzed after 3 days. 
 
Inhibition of actin bundles formation  
Cytochalasin D (Goddette and Frieden, 1987), 
that has the ability to bind actin filaments, was use 
to block polymerization and the elongation of actin. 
GFP or GFP/Ras61 transformed cells were 
incubated with culture medium containing 5 μg/ml of 
cytochalasin D (Sigma) and analyzed after 3 days. 
 
Optical and Electron microscopy 
Botryoidal tissue cells were fixed for 2 h in 0.1 
M cacodylate buffer pH 7.2, containing 2 % 
glutaraldehyde. Specimens were then washed in the 
same buffer and postfixed for 2 hrs with 1 % osmic 
acid in cacodylate buffer, pH 7.2. After standard 
serial ethanol dehydration, specimens were 
embedded in an Epon-Araldite 812 mixture. 
Sections were obtained with a Reichert Ultracut S 
ultratome (Leica, Wien, Austria). Semithin sections 
were stained by conventional methods (crystal violet 
and basic fuchsin) according to Moore et al. (1960), 
and subsequently observed under a light 
microscope (Olympus). Data were recorded with a 
DS-5M-L1 digital camera system (Nikon). Images 
were combined with Adobe Photoshop (Adobe 
Systems, Inc.). Thin sections were stained by uranyl 
acetate and lead citrate and observed with a Jeol 
1010 EX electron microscope (Jeol, Tokyo, Japan). 
Data were recorded with a MORADA digital camera 
system (Olympus). 
 
Immunofluorescence staining 
Cultured cells were fixed with 4 % 
paraformaldehyde in phosphate-buffer (PBS) for 30 
min at 4 °C. After washing in PBS cells were pre-
incubated for 30 min in a blocking solution (PBS, 
2 % bovine serum albumin (BSA), tween 0.1 %). 
Cells were then incubated for 1 h at 37 °C with the 
primary antibodies mouse anti-beta actin (Sigma), to 
visualize G-actin, and rabbit anti-Ras (StressGen 
Biotechnologies Corp.), diluted 1:100 in blocking 
solution. The washed specimens were incubated for 
1 h at room temperature with the appropriate 
secondary antibody Cy3 conjugated (1:200) 
(Jackson, Immuno Research Laboratories, West 
Grove, PA, USA). Samples were directly examined 
with a fluorescence microscope Olympus or 
embedded in Polyfreeze tissue freezing medium 
(Polysciences, Eppelheim, Germany), immediately 
frozen in liquid nitrogen. and cut with a Leica CM 
1850. The staining was visualized using 
excitation/emission filters 550/580 nm for Cy3. Data 
were recorded with a DS-5M-L1 digital camera 
system (Nikon). Images were combined with Adobe 
Photoshop (Adobe Systems, Inc.). In control 
samples, primary antibodies were omitted and cells, 
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Fig. 2 A-L Ectopic expression of Ras61 enhances a dehiscent process in botroyidal tissue cells. The morphology 
of GFP transformed botryoidal cells in growth medium (A, B) and sectioned (E) is similar to that observed in 
control untreated cells. Botryoidal tissue cells maintain a rope shape. In cultured (C, D) and sectioned (F) 
GFP/RAS61 transformed cells morphological changes are observed. Botryoidal tissue cells show an elongated 
phenotype (C, D) and undergo a dehiscence process lining a new cavity (lv in F). The expression of RAS was 
detected by immunofluorescence in both GFP (G-I) and GFP/RAS61 (J-L) transformed cells. After RAS61 
transfection, the expression of RAS protein (in red in H, I, K, L) is mainly localized in the elongated and flattened 
endothelial cells (J-L). The GFP marker indicates infected cells (green in B, D, H, I. K, L). Bars in A-L: 25 μm. 
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pre-incubated for 30 min with PBS/BSA, were 
incubated only with the secondary antibodies. To 
visualize F-actin filaments, cells were treated for 10 
min at 4 °C with a permeabilizing solution (HEPES 
20 mM, pH 7.4, 300 mM sucrose, 50 mM NaCl, 3 
mM MgCl2, 0.5 % Triton X-100), then washed with 
PBS buffer and finally incubated 1 h at 37 °C with 
tetramethylrhodamine (TRITC)-labeled phalloidin 
(Sigma) (diluted 50 μg/ml) in PBS buffer. 
 
Results 
 
Morphological analysis of cultured botryoidal tissue 
cells 
Cultured botryoidal tissue, extracted from 
untreated control leech, is formed by clustered cells 
mostly packed in cord or lining practically virtual 
spaces (Figs 1A, B). These cells (de Eguileor et al., 
2001) belong to different categories due to their size 
and to the presence of large amount of granules in 
the cytoplasm: large roundish granular botryoidal 
and small flattened endothelial-like cells are easily 
recognizable (Figs 1A, B). 
 
Effects of VEGF in vitro 
The VEGF administration (Figs 1C, D) is 
responsible of botryoidal tissue cells changes. A 
dehiscence process led the compact cell cords to 
gradually line new cavities. During early phases of 
angiogenesis (i.e., during the formation of 
prevascular lacunae), botryoidal cells acquired a 
semilunar shape (Figs 1C, D) while small, flattened 
and elongated endothelial-like cells become visible 
interposed among botryoidal ones (Figs 1C, D). 
Unlike control, VEGF stimulated endothelial-like 
cells showed bundles of cytoskeletal filaments (Figs 
1E, F). 
 
Characterization of cultured botryoidal tissue cells 
cytoskeleton 
After VEGF administration, botryoidal tissue 
cells, showing an elongated phenotype, displayed a 
weak expression of anti-beta actin that localize 
diffuse G-actin, and a strong TRITC-conjugated 
phalloidin staining F-actin (i.e., detecting filament 
bundles) (Figs 1G, H). In contrast VEGF/anti-Ras 
treated cells showed a high positivity for the beta-
alpha actin antibody while a low signal was 
detectable for F-actin staining (Figs 1I, J).  
 
Effect of Ras61 on botryoidal tissue cells 
Botryoidal tissue cells have been transformed 
both with GFP and Ras61 (constitutively activated 
RAS protein) in order to: a) define the effects of Ras 
activation on botryoidal tissue phenotypes; b) to 
determine whether Ras activation was sufficient to 
cause actin filaments polymerization, driving 
angiogenic responses without the synergistic VEGF 
induction. Botryoidal tissue cells co-expressing 
Ras61 and GFP showed transformed phenotype 
(Figs 2A-F). Cells expressing only GFP maintained 
a cord shape (Figs 2 A, B, E) while the ectopic 
expression of Ras61 promoted in vitro the 
elongation and the formation of new vessels, (Figs 2 
C, D, F). The ectopic expression of Ras61 in both 
GFP and GFP/Ras61 co-transfected cells was 
evaluated by using an antibody anti-Ras. In the 
control GFP transfected cells, Ras was low 
expressed at the periphery of the botryoidal tissue 
cells organized in clusters (Figs 2G-I). In contrast, in 
RAS61 transformed cells, Ras signalling was strong 
and it was mainly localized in the flattened endothelial 
cells lining the new lumen of vessel (Figs 2J-L). 
Paralleling, cells expressing only GFP showed 
a strong peripheral localization of G actin (Fig. 3A), 
and a weak rhodamine-phalloidin positivity 
indicating that there were very few actin filaments 
(Fig. 3B) as also ultrastructurally validated (Fig. 3C). 
In GFP/Ras61 co-transfected cells (Figs 3D-F) the 
presence of F-actin (confirmed by staining with 
TRITC-phalloidin), mainly located at level of 
endothelial like cells, was preponderant in respect to 
G-actin (confirmed by staining with anti-beta actin). 
The presence of filament bundles was verified by 
ultrastructural analysis (Figs 3F). 
Therefore, we assessed the role of Ras 
signalling in endothelial cells cytoskeleton 
reorganization by inhibition of Ras signalling in Ras 
transformed cells. The effect of Ras was abolished 
when an antibody anti-Ras or the selective MAP 
kinase kinase 1 (MEK1) inhibitor, PD 098059, were 
administrated in vitro (Figs 4 A, B). A similar result 
was obtained adding to the culture medium the 
inhibitor of actin polymerization Cytochalasin D (Fig. 
4C). All three different treatments inhibited the 
formation of F-actin, as shown by TRITC-phalloidin 
staining (Figs 4 D-F) blocking the consequent 
modification of the botryoidal tissue shape. 
 
Discussion 
 
Reorganization of the actin cytoskeleton, 
composed of actin filaments and many specialized 
actin-binding proteins (Stossel, 1993; Small, 1994; 
Zigmond, 1996; Takai et al., 2001), has a key role in 
many cellular functions such as cytokinesis, change 
of cell shape, cell motility and cell adhesion. The 
modulations of actin scaffold is due to the tightly 
regulated polymerization and depolymerisation of 
actin filaments and numerous studies have 
identified in GTPase Ras intervention the clou event 
leading to remodelling of the actin cytoskeleton 
(Joneson et al. 1996; Serban et al., 2008). In 
vertebrates Ras activation is sufficient to induce 
many of the requisite phenotypes for angiogenesis 
by inducing profound morphological changes of the 
vascular endothelium (Xu, et al., 1998), however 
discordant opinions are about the importance in 
assigning the different factors involvement. In fact it 
is known that Ras signalling, even if its mode of 
action is unclear, is capable of driving an angiogenic 
switch in the phenotype of primary endothelial cells 
in the absence of angiogenic factors (Meadows et 
al., 2004). In addition some evidences have 
accumulated that both the classical extracellular 
activated kinase ERK1/2 mitogen activated protein 
(MAP) kinase pathway and the phosphoinositide 3-
kinase (PI 3-kinase) pathway can contribute to 
alterations in the actin cytoskeleton (Castro Barros 
and Marshall,  2005). 
To assess the role of Ras/MAP/ERK signalling 
on cells shape modification we used, as an in vitro 
approach, the botryoidal tissue of H. medicinalis. 
This tissue (made of endothelial and botryoidal cells) 
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Fig. 3 A-F Analysis of cytoskeleton in sectioned GFP and GFP/RAS61 transformed cells. Distribution of diffuse 
and polymerized actin in transformed cells is assessed respectively with an anti-beta actin antibody (A, B) and by 
staining with -phalloidin (D, E). GFP transformed cells contain more diffuse actin (red in A) than polymerized F-
actin (red in B), as also showed by electron microscopy image (C). In GFP/RAS61 tranformed cells a down-
regulation of G-actin isoform (red in D) and a strong signal for F-actin (red in E) is observed. Bundles of actin 
filaments are visible at TEM (arrowhead in F). The GFP marker indicates infected cells (green in A, B, D, E). lv: 
lacunae vessel; n: nucleus. Bars in A, B, D, E: 10 μm; bar in C: 400 nm; bar in F: 200 nm. 
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can be considered an useful tool to evaluate Ras 
effects on cell shape modification since it, during 
angiogenesis in response to VEGF administration, 
undergoes to a radical remodelling leading to 
prevascular/vascular lumen formation characterized 
by marked cellular changes (i.e., by flattening, 
lengthening and stretching especially of endothelial-
like cells (de Eguileor et al., 2001b). 
An interesting outcome of our investigation 
showed that constitutively activated protein Ras61 
expression in stably transfected cells causes 
modification of actin cytoskeleton with vessels 
cavities formation also in total absence of the 
angiogenic factors VEGF, whereas cells expressing 
only GFP show the typical solid cord structure of un-
stimulated tissue. Moreover the angiogenic 
phenotype in both GFP/Ras61 transformed cells 
and VEGF stimulated cells was inhibited by using 
an antibody anti-Ras. 
Immunodetection and ultrastructural analysis of 
cytoskeleton alterations of both VEGF stimulated 
and Ras61-transformed botryoidal tissue cells show 
the presence of oriented bundles of polymerized 
filaments in all botryoidal tissue cells. These cells 
with an elongated and flattened shape are 
characterized by actin filament bundles and in their 
cytoplasm the presence of polymerized F-actin 
(rhodamine-phalloidin positivity) is predominant in 
respect to G actin (anti-beta globular actin positivity). 
These data are validated by treatment of 
GFP/RAS61 co-transfected botryoidal tissue cells 
with Cytochalasin D, an inhibitor of F-actin 
polymerization (Goddette and Frieden, 1987), 
leading to disappearance of actin bundles (decrease 
in fluorescence intensity of phalloidin). On the 
contrary, the diffuse distribution of G-actin, 
challenges the hypothesis of the relationship 
between down-regulation of actin polymerization 
and morphological changes of botryoidal tissue 
cells. 
We demonstrate also that MAP kinase activity 
is essential to the maintenance of the Ras-induced 
phenotype, utilizing a potent inhibitor, the PD 
098059 that reduces the basal MAP kinase activity 
in Ras-transformed botryoidal cells that are unable 
to form vessels. 
Summarizing: i) RAS is the most involved factor in 
actin cytoskeleton reorganization of botryoidal tissue 
cells; ii) the cytoskeletal reorganization of botryoidal 
tissue cells lead to new vessel formation; iii) 
Ras/MAP/ERK signalling on actin filaments 
polymerization and their spatial arrangements are 
directly involved in the morphological modification of 
botryoidal tissue cells. 
 
 
 
 
 
 
 
 
Fig. 4 A-F Effect of anti-RAS; PD 098059 and Cytochalasin D on RAS61 activated cells. A-C: semithin sections of 
RAS-61 transformed botryoidal tissue cells. The anti-Ras antibody (A), the MAP kinase kinase 1 (MEK1) inhibitor 
PD09805 (B) and the inhibitor of actin polymerization Cytochalasin D (C) inhibit Ras induced vessel formation. D-
F: cryosections of GFP/RAS-61 co-transformed botryoidal tissue cells treated with anti-Ras antibody (D), the MAP 
kinase kinase 1 (MEK1) inhibitor PD09805 (E) and the inhibitor of actin polymerization Cytochalasin D (F). A low 
signal for F-actin is detected with TRITC-conjugated phalloidin (red in D-F). Bars in A, B, D, E: 10 μm; bars in C, 
F: 5 μm. 
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